Grow your business safely with PAC PHARMA

All the information you need about PAC PHARMA to develop and secure your business in France

P HOME > CORPORATES > PAC PHARMA > BALANCE SHEET ( 2018-05-14)

THE LIST OF BALANCE SHEET : PAC PHARMA

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-12-08 Public 2022-04-30 Simplified
2020-12-17 Public 2020-04-30 Complete
2020-01-14 Public 2019-04-30 Complete
2019-02-08 Public 2018-04-30 Complete
2018-05-14 Public 2016-12-31 Complete
NamePAC PHARMA
Siren820955094
Closing2016-12-31
Registry code 1704
Registration number 2653
Management number2016B00664
Activity code 6420Z
Closing date n-11901-01-01
Duration Fiscal year 06
Duration Fiscal year n-100
Filing date2018-05-14
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address17600 Le gua
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
014 Intangible Assets - Other 52 080.00 1 157.00 50 922.00 52 080.00
040 Financial Assets 1 424 815.00 1 424 815.00 1 424 815.00
044 Total Fixed Assets 1 476 896.00 1 157.00 1 475 738.00 1 476 896.00
072 Receivables – Other 95 100.00 95 100.00 95 100.00
084 Cash 1 592.00 1 592.00 1 592.00
096 Total Current Assets + Prepaid Expenses 96 692.00 96 692.00 96 692.00
110 Total Assets 1 573 588.00 1 157.00 1 572 430.00 1 573 588.00
120 Share or Individual Capital 32 000.00
134 Retained Earnings -441.00
136 Profit for the Year -3 679.00
142 Total Equity - Total I 27 879.00
156 Loans and similar debts 990 000.00
169 Other debts including current accounts of partners for fiscal year N 554 551.00
172 Other debts 554 551.00
176 Total debts 1 544 551.00
180 Liabilities Total 1 572 430.00
182 Cost of fixed assets acquired or created during the financial year 1 444 990.00
195 Of which payables due in more than one year 1 406 592.00
AB Establishment Expenses 2 005.00 189.00 1 816.00 2 005.00
BJ TOTAL (I) 31 905.00 189.00 31 716.00 31 905.00
BZ Other receivables 95 100.00 95 100.00 95 100.00
CF Cash and cash equivalents 142.00 142.00 142.00
CJ TOTAL (II) 95 242.00 95 242.00 95 242.00
CO Grand total (0 to V) 127 147.00 189.00 126 958.00 127 147.00
CR Shares due in more than one year 95 000.00 95 000.00
CU Other investments 29 900.00 29 900.00 29 900.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
242 Other external expenses 63.00 63.00
254 Depreciation and amortization 968.00 968.00
264 Total operating expenses 1 031.00 1 031.00
270 Operating profit -1 031.00 -1 031.00
294 Financial expenses 2 647.00 2 647.00
310 Profit or loss -3 679.00 -3 679.00
DA Share or individual capital 32 000.00 32 000.00
DI RESULTS FOR THE YEAR (Profit or Loss) -441.00 -441.00
DL TOTAL (I) 31 558.00 31 558.00
DV Miscellaneous Loans and Financial Debts (4) 95 400.00 95 400.00
EC TOTAL (IV) 95 400.00 95 400.00
EE Grand total (I to V) 126 958.00 126 958.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
412 INCREASES Intangible assets – Other Fixed Assets 50 075.00 50 075.00
482 INCREASES Financial Assets 1 394 915.00 1 394 915.00
490 Total Fixed Assets (Gross Value) 31 905.00 31 905.00
492 Total Fixed Assets (Increases) 1 444 990.00 1 444 990.00
FW Other purchases and external expenses 252.00
GA Operating Expenses - Depreciation and Amortization 189.00
GF Total Operating Expenses (II) 441.00
GG - OPERATING RESULT (I - II) -441.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) -441.00
4 - Income statement (continued)Amount year NAmount year N-1
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 441.00 441.00
HN PROFIT OR LOSS (Total revenue - Total expenses) -441.00 -441.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 31 905.00
CZ ACQUISITIONS: Establishment, Development, or Research Expenses 2 005.00
I3 DECREASES Total Financial Fixed Assets 29 900.00
I4 DECREASES Grand Total 31 905.00
IN DECREASES Start-up, development, or research expenses 2 005.00
LQ ACQUISITIONS Total Financial Fixed Assets 29 900.00
6 - Depreciation Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
0N DEPRECIATION Grand Total 189.00
CY DEPRECIATION Start-up, development, or research expenses 189.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
VI Group and Associates 95 400.00 95 400.00 95 400.00
VR Miscellaneous debtors (including receivables related to repo transactions) 95 100.00 95 100.00
VT TOTAL – STATEMENT OF RECEIVABLES 95 100.00 100.00 95 000.00 95 100.00
VY TOTAL – STATEMENT OF LIABILITIES 95 400.00 95 400.00 95 400.00

all companies in France

Complete and comprehensive database.